Leukocyte and platelet aggregation in patients with ischemic stroke: a case-control study

Area of Science:

• Neuroscience
• Immunology
• Cardiovascular Medicine

Background:

• Atherothrombotic stroke involves complex inflammatory and thrombotic processes.
• Leukocyte and platelet activation are implicated in stroke pathophysiology.
• Understanding their distinct roles is crucial for targeted therapies.

Purpose of the Study:

• To simultaneously evaluate leukocyte and platelet aggregation in patients with recent atherothrombotic stroke.
• To compare aggregation levels between patients and healthy controls.
• To investigate the correlation between aggregation patterns and neurological deficit severity.

Main Methods:

• Simultaneous assessment of leukocyte and platelet aggregation.
• Comparison between 40 untreated atherothrombotic stroke patients and 40 matched healthy controls.
• Stratification of patients based on neurological deficit severity (major vs. minor).

Main Results:

• Both leukocyte and platelet aggregation were significantly elevated in stroke patients compared to controls (p < 0.01 and p < 0.02).
• Leukocyte aggregation was significantly higher in patients with major neurological deficits (71%) versus minor deficits (19%; p = 0.04).
• Platelet aggregation levels did not differ significantly between patient groups with varying neurological deficit severity.

Conclusions:

• Leukocyte and platelet aggregation exhibit different activation patterns in ischemic stroke.
• Leukocyte aggregation may serve as a potential biomarker for stroke severity.
• These findings highlight distinct pathophysiological roles and potential clinical implications for leukocyte and platelet activation in stroke.